September 11, 2008
SOUTH EASTON, Mass., Sept. 11 -- Pressure BioSciences, Inc. (Nasdaq: PBIO - News; "PBI" or "the Company") today announced that it has entered into a Cooperative Research and Development Agreement (CRADA) with the United States Army Medical Research Institute of Infectious Diseases (USAMRIID). Researchers at USAMRIID have recently shown that the use of the Company's [...]
September 10, 2008
COLUMBIA, Md., Sept. 10 -- A top 5 bio-pharmaceutical company has licensed BioFortis' Labmatrix(TM) software for use enterprise-wide, across multiple therapeutic areas within its global Translational Medicine organization, BioFortis officials announced today. This large biopharmaceutical company decided to adopt the Labmatrix technology after an extensive review process that included a pilot by end users and [...]
Symyx Enables Enterprise Information Integration and Decision-Making With Release of Isentris 3.1
September 10, 2008
Symyx Technologies, Inc. (NASDAQ: SMMX) announces a significant new release of the Symyx Isentris(R) informatics system that provides many new, productivity-enhancing capabilities. Isentris 3.1 gives scientists the freedom to create, manage, and share fully searchable local databases and to work offline. This functionality goes well beyond Symyx's industry-leading ISIS software, and version 3.1 provides an [...]
September 10, 2008
Stratech Scientific APAC are the new exclusive suppliers of the Expedeon (formerly known as Novexin) range of protein processing and analysis technology products. From Sydney Australia, Stratech Scientific APAC will supply Expedeon's complete product range. Stratech APAC, Ltd. located in Sydney, Australia, will provide the complete range of Expedeon products including their Nvoy technology for [...]
Promega Maxwell® 16 System First Personal Automation™ System to Offer User Programmability
September 10, 2008
MADISON, Wis.--Promega Corporation announces the release of the Maxwell 16 Flexi Method Firmware, a new Maxwell software operating system providing users with the most flexibility and control of automated instrument operation. The new functionality helps research labs develop and optimize instrument methods, maximizing performance for unique sample types and addressing specific application requirements. The new [...]
Advalytix Announces Study of Single Circulating Tumor Cells with the M. D. Anderson Cancer Center
September 10, 2008
MUNICH, Germany--The Advalytix product team of Olympus is initiating a collaborative study with The University of Texas M. D. Anderson Cancer Center to characterize circulating tumor cells in breast cancer patients. The study combines Advalytix’s sensitive AmpliGrid molecular analysis platform, multiplex primer design, and integrated workflow to analyze expression of multiple target genes in single [...]
Bruker Introduces HyperQuant™, a Unique Bench-Top NMR Reader to Quantify Hyperpolarization
September 10, 2008
NICE, France-- At the 2008 World Molecular Imaging Congress (for details, see www.wmicmeeting.org), Bruker BioSpin introduces HyperQuant™, a bench-top NMR reader for precisely quantifying both the magnetic hyperpolarization as well as the thermal polarization of a sample. The HyperQuant applies time-domain nuclear magnetic resonance (TD-NMR) spectroscopy, a technology similar to magnetic resonance imaging (MRI). Magnetic [...]
The California Nanosystems Institute at UCLA Purchases Preclinical Optical Molecular Imaging System
September 10, 2008
ART Advanced Research Technologies Inc. ("ART") (TSX: ARA), a Canadian medical device company and a leader in optical molecular imaging products for the healthcare and pharmaceutical industries, is pleased to announce the sale of the optical molecular imaging Optix(R) MX2 system to the California NanoSystems Institute (CNSI) at UCLA, in Los Angeles. The CNSI will [...]
Cyclex and AnaSpec Sign Licensing Agreement for Deacetylase Activity Assay Kits – September 10, 2008
September 10, 2008
AnaSpec and Cyclex Co. Ltd. today announced a licensing agreement that will allow AnaSpec to make, use, and sell deacetylase activity assay kits and the related products as covered by Cyclex’s patent # ‘s EP 1243658, US 7033778, US 7256013. "We are pleased to partner with Cyclex in expanding our array of next generation assay [...]
Molecular Sensing Inc. (MSI) Announces Signing of CRADA with the Center for Disease Contron (CDC)
September 10, 2008
The CDC to Develop MSI’s Back-Scattering Interferometry Technologyas a Diagnostic Platform for the Detection of Infectious Disease and Typing of Causative Agents Montara, California, September 9th, 2008- Today, Molecular Sensing, Inc. (MSI), an early stage biotechnology company, announces the signing of a Cooperative Research and Development Agreement (CRADA) with the Centers for Disease Control’s, National [...]

